MoneyWorks4Me

Alivus Life Sciences - Quaterly Results

23 Jan 2025 Evaluate
A fair growth of 12.05% in the revenue at Rs. 6418.44 millions was reported in the December 2024 quarter as compared to Rs. 5728.04 millions during year-ago period.A slim rise of 15.32% was recorded in the Net profit for the quarter ended December 2024 to Rs. 1369.60  millions  From Rs. 1187.65 millions.Operating profit for the quarter ended December 2024 rose to 2007.64 millions as compared to 1742.47 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 6418.44 5728.04 12.05 17373.39 17466.17 -0.53 22832.14 21612.20 5.64
Other Income 104.56 16.91 518.33 244.82 89.11 174.74 120.42 289.57 -58.41
PBIDT 2007.64 1742.47 15.22 5086.34 5417.12 -6.11 6862.88 6712.50 2.24
Interest 4.58 3.87 18.35 11.54 11.82 -2.37 15.46 5.47 182.63
PBDT 2003.06 1738.60 15.21 5074.80 5405.30 -6.11 6847.42 6707.03 2.09
Depreciation 151.59 131.77 15.04 446.39 389.18 14.70 534.52 420.94 26.98
PBT 1851.47 1606.83 15.23 4628.41 5016.12 -7.73 6312.90 6286.09 0.43
TAX 481.87 419.18 14.96 1190.82 1286.60 -7.44 1604.02 1616.48 -0.77
Deferred Tax 13.81 30.57 -54.82 45.19 75.00 -39.75 81.88 110.37 -25.81
PAT 1369.60 1187.65 15.32 3437.59 3729.52 -7.83 4708.88 4669.61 0.84
Equity 245.07 245.05 0.01 245.07 245.05 0.01 245.05 245.05 0.00
PBIDTM(%) 31.28 30.42 2.82 29.28 31.01 -5.60 30.06 31.06 -3.22
Peers
Company Name CMP
Sun Pharma. Inds. 1843.05
Dr. Reddys Labs. 1218.00
Cipla 1386.80
Lupin 2062.65
Zydus Lifesciences 1222.90
View more..